MedTrace Logo

High Velocity Nasal Insufflation (Hi-VNI) Use in Upper Airway Surgery

NCT05090852 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2022-10-13

Study results available
· View outcomes & findings →

Summary

The goals of this study are to establish the efficacy of Hi-VNI (High Velocity Nasal Insufflation) in upper airway surgery from the anesthesiologist's and surgeon's perspectives, and to describe the ideal patient and the ideal pathology as well as suitable clinical scenarios when this oxygenation technique should be selected.

Conditions

  • Upper Airway Surgery

Interventions

DEVICE

Hi-VNI

Hi-VNI used instead of or along with endotracheal intubation or jet ventilation to provide oxygen to patients during upper airway surgery

Sponsors & Collaborators

  • Natasha Mirza

    lead OTHER

Principal Investigators

  • Natasha Mirza, MD · Department of Otorhinolaryngology - Head and Neck Surgery

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-22
Primary Completion
2021-09-30
Completion
2021-09-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05090852 on ClinicalTrials.gov